Status: Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
The ASCENTRA-UC study is a phase 2 study testing PALI-2108 in patients with moderate to severe ulcerative colitis. Doses of drug will be compared against a placebo to see how well it works, how safe it is, and how the body responds to it.
Participants needed: 204
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Palisade BioUpdated: Sep 29, 2026Locations: 115
Eligibility criteria
Documented clinical diagnosis of UC for ≥ 3 months prior to Screening. The diagn... [+6]
UC limited to rectum (< 15 cm from anal verge). [+4]